Search
Menu
Bristol Instruments, Inc. - 872 Series High-Res 4/24 LB

Samsung Biologics Names John Rim President and CEO

Facebook X LinkedIn Email
INCHEON, South Korea, Dec. 22, 2020 — Samsung Biologics named John Rim as its president and CEO effectively immediately. Since 2018, he has served as executive vice president at Samsung Biologics. Previously Rim worked for Genentech/Roche in a variety of senior global leadership roles. He also served in leadership roles at Astellas Pharma.Read full article

Related content from Photonics Media



    Articles


    Products


    Photonics Handbook Articles


    White Papers


    Webinars


    Photonics Dictionary Terms


    Media


    Photonics Buyers' Guide Categories


    Companies
    Published: December 2020
    BusinessBiophotonicspharmaceuticalSamsungSamsung BiologicsmicrobiologyMicroscopyspectroscopytestingappointmentscompany appointmentsCEOCEO appointmentpeopleAsia-Pacific

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.